Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood

Journal of Immunological Methods

Volumn 362, Issue 1-2, 2010, Pages 168-175

  Van Brussel, Ilse ^a   Van Vré, Emily A ^a   De Meyer, Guido R Y ^a   Vrints, Christiaan J ^a,b   Bosmans, Johan M ^a,b   Bult, Hidde ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Circulating dendritic cells; Coronary artery disease; Dendritic cell activation; Dendritic cell subset markers; Flow cytometry

Indexed keywords

BLOOD DC ANTIGEN 1; BLOOD DC ANTIGEN 2; BLOOD GROUP ANTIGEN; CD123 ANTIGEN; GLYCOPROTEIN P 15095; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL COUNT; CELL STIMULATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, CD11C; ANTIGENS, SURFACE; CORONARY ARTERY DISEASE; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; MALE; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 77958454888     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.09.031     Document Type: Article

References (28)

1. Agis H., Fureder W., Bankl H.C., et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 1996, 87:535.
2. Aranami T., Miyake S., Yamamura T. Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis. J. Immunol. 2006, 177:5659.
3. Athanassopoulos P., Balk A.H., Vaessen L.M., et al. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy. Int. J. Cardiol. 2009, 131:246.
4. Bobryshev Y.V. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur. Heart J. 2005, 26:1700.
5. Brunialti M.K., Martins P.S., Barbosa de C.H., Machado F.R., Barbosa L.M., Salomao R. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 2006, 25:351.
6. Della Bella S., Giannelli S., Taddeo A., Presicce P., Villa M.L. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J. Immunol. Meth. 2008, 339:153.
7. Dzionek A., Fuchs A., Schmidt P., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 2000, 165:6037.
8. Fangmann J., Wegmann C., Hoppe A., et al. Characterization of dendritic cell subsets in patients undergoing renal transplantation. Transplant. Proc. 2007, 39:3101.
9. Hiasa Y., Akbar S.M., Abe M., Michitaka K., Horiike N., Onji M. Dendritic cell subtypes in autoimmune liver diseases; decreased expression of HLA DR and CD123 on type 2 dendritic cells. Hepatol. Res. 2002, 22:241.
10. Kadowaki N., Ho S., Antonenko S., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001, 194:863.
11. Link A., Bohm M. Potential role of dendritic cells in atherogenesis. Cardiovasc. Res. 2002, 55:708.
12. Moretti S., Lanza F., Dabusti M., et al. CD123 (interleukin 3 receptor alpha chain). J. Biol. Regul. Homeost. Agents 2001, 15:98.
13. Niessner A., Weyand C.M. Dendritic cells in atherosclerotic disease. Clin. Immunol. 2010, 134:25.
14. O'Doherty U., Peng M., Gezelter S., et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994, 82:487.
15. Patsouris D., Li P.P., Thapar D., Chapman J., Olefsky J.M., Neels J.G. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008, 8:301.
16. Pichyangkul S., Yongvanitchit K., Kum-arb U., Krieg A.M., Heppner D.G., Walsh D.S. Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides. J. Immunol. Meth. 2001, 247:83.
17. Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 2001, 45:194.
18. Sadhu C., Ting H.J., Lipsky B., et al. CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. J. Leukoc. Biol. 2007, 81:1395.
19. Shi H., Ge J., Fang W., et al. Peripheral-blood dendritic cells in men with coronary heart disease. Am. J. Cardiol. 2007, 100:593.
20. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973, 137:1142.
21. Sun Q., Woodcock J.M., Rapoport A., et al. Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist. Blood 1996, 87:83.
22. Van Vré E.A., Hoymans V.Y., Bult H., et al. Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coron. Artery Dis. 2006, 17:243.
23. Van Vré E.A., Bult H., Hoymans V.Y., Van Tendeloo V., Vrints C.J., Bosmans J.M. Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation. Arterioscler. Thromb. Vasc. Biol. 2008, 28:511.
24. Van Vré E.A., Van Brussel I., de Beeck K.O., et al. Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function. Coron. Artery Dis. 2010, 21:87.
25. Vela-Ojeda J., Garcia-Ruiz Esparza M.A., Reyes-Maldonado E., et al. Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma. Ann. Hematol. 2006, 85:308.
26. Wu P., Wu J., Liu S., et al. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin. Immunol. 2008, 129:40.
27. Yilmaz A., Weber J., Cicha I., et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J. Am. Coll. Cardiol. 2006, 48:70.
28. Yilmaz A., Schaller T., Cicha I., et al. Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease. Clin. Sci. Lond 2009, 116:353.